Collection of Data and Samples From Healthy Donors for Use in Translational Research

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorNational Institute of Allergy and Infectious Diseases (NIAID)

About this trial

Increased numbers of white blood cells called eosinophils can cause disease. To investigate this disease, researchers need blood, urine, sputum, stool, cerebrospinal fluid, skin and/or bone marrow samples to compare to samples from patients with this problem. Some of the samples will be used for genetic testing or future research.

This study will last for about 10 years and will include a maximum of 50 paid volunteers ages 18 to 65.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

ability to sign informed consent

healthy male or female

18-85 years of age

Disqualifiers

pregnancy

weight <110 pounds

history of heart, lung, kidney disease, chronic anemia or bleeding disorders

ability to sign informed consent

Trial population

Healthy volunteers.

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

Not listed

Trial groups

250 Participants
are grouped into 1 trial group
Group A: Healthy volunteer

Trial outcomes

Primary outcomes

1

- To provide an IRB-approved mechanism for the collection of peripheral blood, urine, sputum, stool, cerebrospinal fluid, skin biopsy and bone marrow samples from paid, volunteer donors for use in in vitro studies.

\- To provide adequate and complete informed consent to the donors of research blood samples, and to assure that the education, counseling and protection of the study subjects from research risks is performed in accordance with IRB, OHRP, and other applicable Federal regulatory standards.

Time frame
50 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.